✦ LIBER ✦

Reduction of postprandial blood glucose by theα-glucosidase inhibitor Miglitol (BAY m 1099) in Type II diabetes

✍ Scribed by G. Heinz; M. Komjati; A. Korn; W. Waldhäusl

Publisher: Springer
Year: 1989
Tongue: English
Weight: 502 KB
Volume: 37
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00609420

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of theα-glucosidase inhibitor 1

Effects of theα-glucosidase inhibitor 1 desoxynojirimycin (BAY M 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients

✍ Ch. Schnack; G. Röggla; A. Luger; G. Schernthaner 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 294 KB

Long-term effectiveness of a new α-gluco

Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated Type 2 diabetes mellitus

✍ Mitrakou, A.; Tountas, N.; Raptis, A.E.; Bauer, R.J.; Schulz, H.; Raptis, S.A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

In a double-blind, randomized study, miglitol (BAY m 1099), an ␣-glucosidase inhibitor, 100 mg tds or placebo was given orally with meals for a period of 24 weeks in 117 patients with Type 2 (non-insulin-dependent) diabetes mellitus (DM) treated with insulin. Fasting and 1 h postprandial plasma gluc

Effect of an alpha-glucosidase inhibitor

Effect of an alpha-glucosidase inhibitor (BAY m 1099) on post-prandial blood glucose and insulin in type II diabetics

✍ P. H. Joubert; W. J. Bam; N. Manyane 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 260 KB